Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Henry ScheinHSIC +1.11%81 EV-to-EBITDA is 14.93 as of Jul. 27, 2026, which is 5% above its 10-year median of 14.16. GuruFocus rates HSIC with a GF Score™ of 81/100 and a GF Value™ of $84.14 (Fairly Valued). The stock has 9 warning signs investors should review. Among 98 Medical Distribution companies, Henry Schein ranks worse than 76.53% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Henry Schein's enterprise value is $14,903 Mil.
Henry Schein's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $998 Mil. Therefore, Henry Schein's EV-to-EBITDA for today is 14.93.
The historical rank and industry rank for Henry Schein's EV-to-EBITDA or its related term are showing as below:
HSIC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.21 Med: 14.16 Max: 22.22
Current: 14.93
During the past 13 years, the highest EV-to-EBITDA of Henry Schein was 22.22. The lowest was 9.21. And the median was 14.16.
HSIC's EV-to-EBITDA is ranked worse than 76.53% of 98
companies
in the Medical Distribution industry
Industry Median: 8.67
vs HSIC: 14.93
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Henry Schein (NAS:HSIC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Henry Schein's PE Ratio (TTM) for today is calculated as:
Henry Schein's share price for today is $85.47.
Henry Schein's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.310.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Henry Schein's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Henry Schein's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Henry Schein's EV-to-EBITDA falls into.
Henry Schein's current Enterprise Value is $14,903 Mil.
Henry Schein's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $998 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henry Schein (HSIC) has a EV-to-EBITDA of 14.93 as of Jul. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Henry Schein. This is near median its historical median of 14.16. Over the past decade, Henry Schein's EV-to-EBITDA has ranged from 9.21 to 22.22. According to the industry distribution chart, Henry Schein ranks #75 out of 98 companies in the Medical Distribution industry, placing it in the top 76.5%.
Is Henry Schein's EV-to-EBITDA too high?
Henry Schein's current EV-to-EBITDA of 14.93 is near median its 10-year median of 14.16. Over the past 10 years, this metric has ranged from a low of 9.21 to a high of 22.22. The Medical Distribution industry median EV-to-EBITDA is 8.67. Henry Schein's value of 14.93 is 72.2% above this industry median. Based on the distribution chart, Henry Schein ranks #75 out of 98 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Henry Schein has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's EV-to-EBITDA compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #75 out of 98 companies for EV-to-EBITDA. This places Henry Schein in the lower half of its industry. The industry median EV-to-EBITDA is 8.67. Henry Schein's value of 14.93 is 72.2% above this benchmark. Historically, Henry Schein's own EV-to-EBITDA has ranged from 9.21 to 22.22 over the past decade. While the company's 10-year median is 14.16 vs. the industry median of 8.67, Henry Schein has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.67, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henry Schein's current EV-to-EBITDA of 14.93 is 72.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Henry Schein. For the Medical Distribution industry, the median EV-to-EBITDA is 8.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current EV-to-EBITDA is 14.93, which is near median its own 10-year median of 14.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $84.14, compared to a current price of $85.47 — trading 1.6% above its estimated fair value. The current EV-to-EBITDA is 14.93, which is near median its 10-year median of 14.16 and 72.2% above the Medical Distribution industry median of 8.67. Henry Schein's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Henry Schein (HSIC), the current EV-to-EBITDA is 14.93 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of $85.47 is trading 1.6% above its estimated GF Value™ of $84.14.
GuruFocus considers Henry Schein to be Fairly Valued.
Key valuation signals for HSIC:
EV-to-EBITDA: 14.93 (near median its 10-year median of 14.16)
GF Value™: $84.14 vs. price of $85.47 (1.6% above fair value)
Industry Position: 72.2% above the Medical Distribution median (#75 of 98)
No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
81GF Score
Get the complete analysis for HSIC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSIC has been successfully added to your 
